image
Apellis Pharmaceuticals, Inc. APLS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 26.27
-6.38 %
$ 3.27 B
Market Cap
-13.0
P/E
INCOME STATEMENT
397 M REVENUE
425.83%
Growth Rates
1Year 425.83%
3Years 16.53%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-517 M OPERATING INCOME
13.03%
Growth Rates
1Year 13.03%
3Years -34.25%
5Years -32.23%
7Years -52.24%
10Years -62.49%
-529 M NET INCOME
18.94%
Growth Rates
1Year 18.94%
3Years -15.30%
5Years -32.90%
7Years -52.85%
10Years -63.13%
EFFICIENCY
Earnings Waterfall Apellis Pharmaceuticals, Inc.
image
Revenue 397 M
Cost Of Revenue 58.5 M
Gross Profit 338 M
Operating Expenses 855 M
Operating Income -517 M
Other Expenses 11.5 M
Net Income -529 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 396.6 75.4 66.6 250.6 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 58.5 5.6 5.2 25.1 288.0 127.9 50.8 0 0 0 0
Gross Profit 338.1 69.8 61.4 225.6 (288.0) (127.9) (50.8) 0 0 0 0
OPERATING INCOME
Operating Expenses 855.2 664.4 597.6 439.3 288.0 127.9 50.8 27.3 20.1 11.3 4.0
Selling, General and Administrative Expenses 500.8 277.2 176.8 139.4 67.0 22.6 10.5 4.3 6.4 2.9 1.7
Research and Development Expenses 354.4 387.2 420.9 299.9 221.0 105.3 40.3 23.0 13.7 8.4 2.3
Operating Income (517.1) (594.6) (536.3) (213.7) (288.0) (127.9) (50.8) (27.3) (46.6) (11.3) (4.0)
PRE-TAX INCOME
Interest Income Expense 29.6 32.6 13.2 29.9 5.3 2.5 96.9 K 0 0 0 0
Total Other Income (9.4) (56.9) (209.7) (129.3) (16.7) 0.4 (0.2) 0.2 57.1 K 62.5 K 68 K
Pre-Tax Income (526.5) (651.5) (746.0) (343.0) (304.7) (127.5) (51.0) (27.1) (46.5) (11.2) (4.0)
NET INCOME
Tax Provision 2.1 0.7 0.4 1.8 5.1 (0.5) 0.3 (27.3) (26.5) (0.4) 0
Net Income (528.6) (652.2) (746.4) (344.9) (309.8) (127.5) (51.0) (27.1) (46.5) (10.8) (4.0)
EPS 4.45 6.15 8.84 4.59 4.98 2.34 3.68 1.5 2.57 0.6 0.22